The sequential treatment with an OV followed by CKM resulted in the upregulation of Th1-attracting cytokines (CKs) and reduction of Treg-attracting CKs (CCL22 and CXCL12), concurrent with enhanced trafficking of tumor-specific CD8+ T cells and NK cells into the TME. This evidence concerns the gene CXCL12 and neoplasm.